ArticleScientific reports2022

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.

Anand V Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.